Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Burger

Showing results (721-730 of 1,123) with videos related to

Pageof 113
Sort By:
Antiviral Therapy|August 22, 2012
Pharmacokinetics and 48-week safety and efficacy of generic lopinavir/ritonavir in Thai HIV-infected patientsReshmie A Ramautarsing, Jasper van der Lugt, Meena Gorowara, et al.
Biomedical Chromatography : BMC|August 13, 2024
Development and validation of an ultra-performance liquid chromatography-tandem mass spectrometry method to quantify the small molecule inhibitors adagrasib, alectinib, brigatinib, capmatinib, crizotinib, lorlatinib, selpercatinib, and sotorasib in human plasmaEsther M Hollander, Nachel M C Zimmerman, Berber Piet, et al.
The Journal of Pathology|January 1, 2009
Switching of vascular phenotypes within a murine breast cancer model induced by angiopoietin-2Yvonne Reiss, Anette Knedla, Andrea O Tal, et al.
Cancer Research|November 17, 2005
A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancerAngelika M Burger, Yuguang Gao, Yutaka Amemiya, et al.
Journal of Clinical Epidemiology|December 5, 2002
Human papillomavirus testing for triage of women referred because of abnormal smears. a decision analysis considering outcomes and costsWillem Jan Meerding, Marjolein van Ballegooijen, Matthé P M Burger, et al.
British Journal of Cancer|February 16, 2013
Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugsR W F van Leeuwen, D H S Brundel, C Neef, et al.
Therapeutic Drug Monitoring|July 27, 2019
Simple and Rapid Quantification of the Multi-Enzyme Targeting Antifolate Pemetrexed in Human PlasmaErik van den Hombergh, Nikki de Rouw, Michel van den Heuvel, et al.
The Journal of Antimicrobial Chemotherapy|November 13, 2004
Plasma levels of zidovudine twice daily compared with three times daily in six HIV-1-infected childrenAlina S Bergshoeff, Pieter L A Fraaij, Corrien Verweij, et al.
The Pediatric Infectious Disease Journal|May 30, 2006
Adherence and acceptability of once daily Lamivudine and abacavir in human immunodeficiency virus type-1 infected childrenMarthe LePrevost, Hannah Green, Jacquie Flynn, et al.
Cancer Chemotherapy and Pharmacology|January 19, 2026
Mapping drug-drug interactions in pharmacokinetic boosting of olaparibJoanneke K Overbeek, Sarmad M S Naoom, Laura Nijboer, et al.
Pageof 113

Showing results (721-730 of 1,123) with videos related to

Sort By:
Pageof 113
Antiviral Therapy|August 22, 2012
Pharmacokinetics and 48-week safety and efficacy of generic lopinavir/ritonavir in Thai HIV-infected patientsReshmie A Ramautarsing, Jasper van der Lugt, Meena Gorowara, et al.
Biomedical Chromatography : BMC|August 13, 2024
Development and validation of an ultra-performance liquid chromatography-tandem mass spectrometry method to quantify the small molecule inhibitors adagrasib, alectinib, brigatinib, capmatinib, crizotinib, lorlatinib, selpercatinib, and sotorasib in human plasmaEsther M Hollander, Nachel M C Zimmerman, Berber Piet, et al.
The Journal of Pathology|January 1, 2009
Switching of vascular phenotypes within a murine breast cancer model induced by angiopoietin-2Yvonne Reiss, Anette Knedla, Andrea O Tal, et al.
Cancer Research|November 17, 2005
A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancerAngelika M Burger, Yuguang Gao, Yutaka Amemiya, et al.
Journal of Clinical Epidemiology|December 5, 2002
Human papillomavirus testing for triage of women referred because of abnormal smears. a decision analysis considering outcomes and costsWillem Jan Meerding, Marjolein van Ballegooijen, Matthé P M Burger, et al.
British Journal of Cancer|February 16, 2013
Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugsR W F van Leeuwen, D H S Brundel, C Neef, et al.
Therapeutic Drug Monitoring|July 27, 2019
Simple and Rapid Quantification of the Multi-Enzyme Targeting Antifolate Pemetrexed in Human PlasmaErik van den Hombergh, Nikki de Rouw, Michel van den Heuvel, et al.
The Journal of Antimicrobial Chemotherapy|November 13, 2004
Plasma levels of zidovudine twice daily compared with three times daily in six HIV-1-infected childrenAlina S Bergshoeff, Pieter L A Fraaij, Corrien Verweij, et al.
The Pediatric Infectious Disease Journal|May 30, 2006
Adherence and acceptability of once daily Lamivudine and abacavir in human immunodeficiency virus type-1 infected childrenMarthe LePrevost, Hannah Green, Jacquie Flynn, et al.
Cancer Chemotherapy and Pharmacology|January 19, 2026
Mapping drug-drug interactions in pharmacokinetic boosting of olaparibJoanneke K Overbeek, Sarmad M S Naoom, Laura Nijboer, et al.
Pageof 113